CD8A and neoplasm: M2 MDEs can transport ApoE, which interferes with the ATPase activity of binding immunoglobulin protein (BiP), which reduces MHC-I expression on tumor cells and inhibits the ability of CD8+ T cells to exert cytotoxic effects on these cells.